Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Vital Farms, Inc. disclosed that one of its directors and its President and CEO sold common stock in a planned transaction. On December 15, 2025, the reporting person sold 16,734 shares of Vital Farms common stock at a weighted average price of $35.05 per share, with individual sale prices ranging from $35.00 to $35.15. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025, which is designed to allow insiders to sell shares according to a predetermined schedule. After this transaction, the reporting person directly beneficially owned 649,684 shares of Vital Farms common stock.
Vital Farms, Inc. disclosed that it issued a press release titled “Vital Farms Sets $2 Billion Net Revenue Target for 2030; To Host Investor Day in Springfield, Missouri.” The company is publicly setting a long-term goal of reaching $2 billion in net revenue by 2030, giving investors a clear numeric benchmark for its growth ambitions.
The same announcement states that Vital Farms plans to host an Investor Day in Springfield, Missouri, signaling a dedicated event to engage with the investment community. The press release is furnished as Exhibit 99.1 and, as stated in the report, is not deemed “filed” for purposes of Section 18 of the Exchange Act or automatically incorporated into other SEC reports except where specifically referenced.
Vital Farms, Inc. (VITL) reported an insider transaction by its executive chairperson, who is also a director and 10% owner. On 11/24/2025, 880 shares of common stock were surrendered to Vital Farms at a price of $30.67 per share to satisfy withholding tax obligations, which is a non-market transaction typically linked to equity compensation.
After this transaction, the reporting person beneficially owned 6,416,190 shares of Vital Farms common stock directly. An additional 400,000 shares are held indirectly through a former spouse under an agreement that gives the reporting person sole voting control but no pecuniary interest in those shares.
Vital Farms, Inc. (VITL) reported an insider share purchase by its Chief Sales Officer and President, Eggs. On 11/17/2025, the officer acquired 291 shares of common stock at a price of $26.13 per share under the company’s 2020 Employee Stock Purchase Plan. Following this transaction, the officer beneficially owned 65,721 shares in direct ownership. The filing notes that the purchase was made through the employee stock purchase plan at 85% of the closing price on the purchase date and is described as exempt under Rule 16b-3(d) and Rule 16b-3(c).
Vital Farms, Inc. (VITL) reported an insider share purchase by its Chief Financial Officer. On 11/17/2025, the CFO acquired 281 shares of common stock at $26.13 per share under the company’s 2020 Employee Stock Purchase Plan (ESPP). After this transaction, the CFO beneficially owned 59,064 shares of Vital Farms common stock in direct ownership.
The filing notes that the ESPP purchase was exempt under Rules 16b-3(d) and 16b-3(c), and that the shares were bought at a price equal to 85% of the closing price of Vital Farms’ common stock on the purchase date, reflecting the standard discount feature of the ESPP.
Vital Farms, Inc. (VITL) reported an insider share purchase by one of its officers. The company’s General Counsel, Secretary and Head of Impact acquired 258 shares of common stock on 11/17/2025 through the company’s 2020 Employee Stock Purchase Plan.
The shares were bought at a price of $26.13 per share, which the plan sets at 85% of the closing price on the purchase date. Following this transaction, the officer beneficially owns 43,590 shares of Vital Farms common stock, held directly.
Vital Farms, Inc. (VITL) insider President and CEO, who also serves as a director, reported a routine purchase of company stock. On 11/17/2025, the reporting person acquired 309 shares of Vital Farms common stock at a price of $26.13 per share through the company’s 2020 Employee Stock Purchase Plan. After this transaction, the insider beneficially owned 666,418 shares of Vital Farms common stock, held directly. The filing notes that the purchase under the ESPP was structured to be exempt from certain short-swing profit rules under Rule 16b-3.
Vital Farms, Inc. (VITL) filed a Form 4 reporting a routine share purchase by a senior executive. The company’s SVP of Strategy acquired 401 shares of common stock on 11/17/2025 at a price of $26.13 per share under Vital Farms’ 2020 Employee Stock Purchase Plan. After this transaction, the executive beneficially owns 46,180 shares of Vital Farms common stock held directly.
The filing notes that the purchase was made through the employee stock purchase plan at 85% of the common stock’s closing price on the purchase date and was exempt under Rule 16b-3(d) and Rule 16b-3(c). This is an administrative disclosure of insider ownership and does not describe any change to the company’s operations or strategy.
Vital Farms (VITL) — insider stock transactions disclosed. A director, executive chairperson, and 10% owner reported open‑market sales made under a Rule 10b5‑1 trading plan adopted on March 14, 2025.
On 11/03/2025, the Reporting Person sold 21,408 shares at a weighted average price of $31.85, with individual trades ranging from $31.28 to $32.27, and 3,592 shares at a weighted average price of $32.35, with trades from $32.28 to $32.54. On 11/04/2025, 5,000 shares were sold at a weighted average price of $37.78, with trades from $37.01 to $38.00.
Following these transactions, the Reporting Person beneficially owned 6,417,070 shares directly. In addition, 716,000 shares are reported indirectly by a former spouse; per the disclosure, the Reporting Person has sole voting control over these shares and no pecuniary interest.
Vital Farms (VITL) reported strong Q3 fiscal 2025 results. Net revenue rose to $198.9 million from $145.0 million a year ago, driven primarily by eggs and egg-related products at $192.6 million. Gross profit increased to $75.0 million, and net income reached $16.4 million versus $7.4 million. Diluted EPS was $0.36 compared with $0.16.
For the first 39 weeks of fiscal 2025, net revenue was $545.9 million versus $440.3 million, with net income of $50.0 million versus $42.8 million. Customer concentration remained notable, with Customer A representing 24% of Q3 net revenue and 22% year-to-date. Cash and cash equivalents were $93.8 million as of September 28, 2025, alongside $51.3 million of available-for-sale U.S. Treasury Bills.
Operating cash flow was $27.9 million year-to-date, while capital expenditures totaled $44.0 million, lifting property, plant and equipment, net to $121.1 million. The company reported no borrowings on its $60.0 million JPMorgan revolving credit facility. A July 2025 tax law change reduced current tax expense, largely offset by higher deferred tax expense, with no material net effect on the quarter’s effective tax rate.